alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 23,226–23,250 of 27,380 studies, newest first · page 930 of 1096.

March 2006 25

  1. 2006-03-01

    Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

    ✓ Peer-reviewed Drug development Nature clinical practice. Neurology

    Key finding: A number of well-designed epidemiological studies have linked type 2 diabetes mellitus (T2DM) with an increased risk of Alzheimer's disease (AD).

    Full summary, score breakdown and related studies → Original source

  2. 2006-03-01

    Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life

    ✓ Peer-reviewed Treatments Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    Key finding: Cognitive functioning, mood, and health-related QOL were significantly improved following a 24-week course of the acetylcholinesterase inhibitor donepezil. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2006-03-01

    Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease

    ✓ Peer-reviewed Brain scans and imaging Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

    Key finding: Our study confirms some other studies in showing that in AD patients there is a reduction of parapapillary and macular RNFL thickness and macular volume as measured by OCT. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2006-03-01

    Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease

    ✓ Peer-reviewed Tau biomarkers FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    Key finding: Using this ELISA, we report the presence of significantly elevated (P=0.002) levels of oligomeric forms of alpha-syn in plasma samples obtained from 34 PD patients compared with 27 controls; 52% (95% confidence intervals 0.353-0.687) of the PD patients displayed signals >0.5 OD with our ELISA assay in comparison to only 14.8% (95% confidence intervals 0.014-0.281) for the control cases. +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2006-03-01

    Elevation in plasma Abeta42 in geriatric depression: a pilot study

    ✓ Peer-reviewed Biomarkers Neurochemical research

    Key finding: Elevated plasma amyloid beta 1-42 (Abeta42) level has been linked to increased risk for incident AD in cognitively-intact elderly. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2006-03-01

    Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: The cascade of Alzheimer's disease (AD) neurodegeneration is associated with persistent oxidative stress, mitochondrial dysfunction, impaired energy metabolism, and activation of pro-death signaling pathways. +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2006-03-01

    Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives

    ✓ Peer-reviewed Hippocampus size on brain scans The American journal of psychiatry

    Key finding: Schizophrenia and psychotic bipolar disorder are characterized by morphometric distinctions in ventricular and hippocampal regions.

    Full summary, score breakdown and related studies → Original source

  8. 2006-03-01

    Is hospice associated with improved end-of-life care in nursing homes and assisted living facilities?

    ✓ Peer-reviewed End-of-life care Journal of the American Geriatrics Society

    Key finding: Rates of hospice use observed in this study (22%) were considerably higher than previously reported, although persons with dementia may continue to be underreferred. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2006-03-01

    Lower plasma vitamin E levels are associated with the frailty syndrome: the InCHIANTI study

    ✓ Peer-reviewed Clinical safety The journals of gerontology. Series A, Biological sciences and medical sciences

    Key finding: Our findings show an association between low circulating levels of one of the most important components of the human antioxidant system and the presence of frailty. +2 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2006-03-01

    Cognitive processes related to gait velocity: results from the Einstein Aging Study

    ✓ Peer-reviewed Clinical safety Neuropsychology

    Key finding: Regression analyses revealed that these factors were significant predictors of variance in gait velocity, but the relationship varied as a function of task condition. +1 more finding

    Full summary, score breakdown and related studies → Original source

  11. 2006-03-01

    Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials

    ✓ Peer-reviewed Clinical safety The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: Quality of the reporting of trials varied. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2006-03-01

    Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies

    ✓ Peer-reviewed Disease mechanisms Journal of neuropathology and experimental neurology

    Key finding: However, in most of DLB cases, LBs are associated with neurofibrillary tangles and amyloid plaques (both Alzheimer disease [AD]-related lesions). +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2006-03-01

    Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy

    ✓ Peer-reviewed Disease mechanisms The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: We conclude that protein tau plays an important beneficial role in normal neuronal processes of hippocampal memory, and conversely, that not tau mutations per se, but the ensuing hyperphosphorylation must be critical for cognitive decline in tauopathies.

    Full summary, score breakdown and related studies → Original source

  14. 2006-03-01

    Interface between tauopathies and synucleinopathies: a tale of two proteins

    ✓ Peer-reviewed Disease mechanisms Annals of neurology

    Key finding: This overlap extends to the neuropathological findings; the pathognomonic hallmark for one set of disorders, Lewy bodies or neurofibrillary tangles, is present more often than expected in the other set. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2006-03-01

    [Biochemical markers for Alzheimer disease]

    ✓ Peer-reviewed Tau biomarkers Ugeskrift for laeger

    Key finding: Symptomatic treatment now exists which can temporarily inhibit the loss of brain function. +3 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2006-03-01

    Neurobiological studies of dementia--biological markers and neuroprotective strategies for Alzheimer disease

    ✓ Peer-reviewed Tau biomarkers Acta neurologica Taiwanica

    Key finding: Total tau protein in CSF is a biomarker for AD, however increased levels of total tau in CSF were also observed in other neurological disease with dementia. +3 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2006-03-01

    Astaxanthin, a carotenoid with potential in human health and nutrition

    ✓ Peer-reviewed Risk factors Journal of natural products

    Key finding: The potent antioxidant property of 1 has been implicated in its various biological activities demonstrated in both experimental animals and clinical studies. +1 more finding

    Full summary, score breakdown and related studies → Original source

  18. 2006-03-01

    Neurobiology of exercise

    ✓ Peer-reviewed Risk factors Obesity (Silver Spring, Md.)

    Key finding: These adaptations in the central nervous system have implications for the prevention and treatment of obesity, cancer, depression, the decline in cognition associated with aging, and neurological disorders such as Parkinson's disease, Alzheimer's dementia, ischemic stroke, and head and spinal cord injury.

    Full summary, score breakdown and related studies → Original source

  19. 2006-03-01

    Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease

    ✓ Peer-reviewed Caregiving Neuropsychiatric disease and treatment

    Key finding: No correlation with neuropsychiatric symptoms such as apathy and depression was found. +1 more finding

    Full summary, score breakdown and related studies → Original source

  20. 2006-03-01

    Education and rates of cognitive decline in incident Alzheimer's disease

    ✓ Peer-reviewed Caregiving Journal of neurology, neurosurgery, and psychiatry

    Key finding: We conclude that higher education AD patients experience faster cognitive decline. +2 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2006-03-01

    Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study

    ✓ Peer-reviewed Getting a diagnosis Archives of general psychiatry

    Key finding: Depressive symptoms were associated with increased risk of MCI, and this association was independent of underlying vascular disease. +4 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2006-03-01

    Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans

    ✓ Peer-reviewed Getting a diagnosis Annals of neurology

    Key finding: These observations suggest that brain amyloid deposition results in low CSF Abeta(42), and that amyloid imaging and CSF Abeta(42) may potentially serve as antecedent biomarkers of (preclinical) AD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  23. 2006-03-01

    Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

    ✓ Peer-reviewed Getting a diagnosis The Lancet. Neurology

    Key finding: During follow-up, 57 (42%) patients with MCI developed Alzheimer's disease, 21 (15%) developed other forms of dementia, and 56 (41%) remained cognitively stable for 5.2 years (range 4.0-6.8).

    Full summary, score breakdown and related studies → Original source

  24. 2006-03-01

    Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease

    ✓ Peer-reviewed Prevention and risk Journal of the American Geriatrics Society

    Key finding: These effects were most pronounced in caregivers of subjects with Alzheimer's disease.

    Full summary, score breakdown and related studies → Original source

  25. 2006-03-01

    Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial

    ✓ Peer-reviewed Treatments The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: Efficacy analysis included 416 patients. +2 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →